Finance

Lists
007575:KRX
Ilyang Pharmaceutical Co Ltd Preference Shares
7 480,00 KRW
-0,27%
(-20,00) 1D
19 ოქტ, 15:30:00 GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 007575...
Open
7 480 KRW
High
7 480 KRW
Low
7 480 KRW
Mkt. cap
142,86 მლრ.
Avg. vol.
426,00
Volume
11,00
Dividend
2,07%
Quarterly dividend
39 KRW
Ex-dividend date
27 დეკ. 2023
P/E ratio
7,57
52-wk high
15 260 KRW
52-wk low
6 350 KRW
EPS
988 KRW
Shares outstanding
445,08 ათ.
No. of employees
660
Open
7 480 KRW
High
7 480 KRW
Low
7 480 KRW
Mkt. cap
142,86 მლრ.
Avg. vol.
426,00
Volume
11,00
Dividend
2,07%
Quarterly dividend
39 KRW
Ex-dividend date
27 დეკ. 2023
P/E ratio
7,57
52-wk high
15 260 KRW
52-wk low
6 350 KRW
EPS
988 KRW
Shares outstanding
445,08 ათ.
No. of employees
660
News stories
From web sources and news partners
About Ilyang Pharmaceutical Co Ltd Preference Shares
CEOკიმ დონგ-ეონ
Employees660
Founded1 ივლ. 1946
Headquarters-
SectorPharmaceutical industry
Websitehome.ilyang.co.kr
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
68,83 მლრდ.
78,91 მლრდ.
65,07 მლრდ.
65,14 მლრდ.
Cost of goods sold
41,32 მლრდ.
45,42 მლრდ.
40,63 მლრდ.
40,74 მლრდ.
Cost of revenue
41,32 მლრდ.
45,42 მლრდ.
40,63 მლრდ.
40,74 მლრდ.
Research and development expenses
7,01 მლრდ.
7,00 მლრდ.
8,87 მლრდ.
5,94 მლრდ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
19,76 მლრდ.
24,92 მლრდ.
22,29 მლრდ.
22,34 მლრდ.
Operating expense
27,66 მლრდ.
32,93 მლრდ.
31,82 მლრდ.
31,17 მლრდ.
Total operating expenses
68,98 მლრდ.
78,35 მლრდ.
72,44 მლრდ.
71,91 მლრდ.
Operating income
-157,75 მლნ.
565,93 მლნ.
-7,37 მლრდ.
-6,77 მლრდ.
Other non operating income
11,87 მლრდ.
-681,30 მლნ.
24,70 მლრდ.
2,24 მლრდ.
EBT including unusual items
11,42 მლრდ.
-1,72 მლრდ.
17,95 მლრდ.
-5,08 მლრდ.
EBT excluding unusual items
11,35 მლრდ.
-1,72 მლრდ.
17,62 მლრდ.
-5,06 მლრდ.
Income tax expense
3,04 მლრდ.
3,92 მლრდ.
983,97 მლნ.
-2,74 მლრდ.
Effective tax rate
26,58%
-227,04%
5,48%
53,89%
Other operating expenses
639,84 მლნ.
573,32 მლნ.
453,35 მლნ.
433,71 მლნ.
Net income
8,44 მლრდ.
-5,65 მლრდ.
16,80 მლრდ.
-2,29 მლრდ.
Net profit margin
12,26%
-7,16%
25,81%
-3,52%
Earnings per share
-
-
-
-
Interest and investment income
-
184,97 მლნ.
140,72 მლნ.
144,16 მლნ.
Interest expense
-
-738,07 მლნ.
-711,18 მლნ.
-702,63 მლნ.
Net interest expenses
-
-553,10 მლნ.
-570,46 მლნ.
-558,47 მლნ.
Depreciation and amortization charges
212,18 მლნ.
210,49 მლნ.
211,82 მლნ.
220,64 მლნ.
EBITDA
1,93 მლრდ.
2,65 მლრდ.
-5,30 მლრდ.
-4,54 მლრდ.
Gain or loss from assets sale
-71,72 მლნ.
6,86 ათ.
-
31,87 მლნ.
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები